894 related articles for article (PubMed ID: 10422996)
1. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
[TBL] [Abstract][Full Text] [Related]
2. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study.
Klopotowska JE; Kuiper R; van Kan HJ; de Pont AC; Dijkgraaf MG; Lie-A-Huen L; Vroom MB; Smorenburg SM
Crit Care; 2010; 14(5):R174. PubMed ID: 20920322
[TBL] [Abstract][Full Text] [Related]
3. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units.
Kucukarslan SN; Peters M; Mlynarek M; Nafziger DA
Arch Intern Med; 2003 Sep; 163(17):2014-8. PubMed ID: 14504113
[TBL] [Abstract][Full Text] [Related]
4. Pharmacist interventions during patient rounds in two intensive care units: Clinical and financial impact.
Bosma BE; van den Bemt PMLA; Melief PHGJ; van Bommel J; Tan SS; Hunfeld NGM
Neth J Med; 2018 Apr; 76(3):115-124. PubMed ID: 29667584
[TBL] [Abstract][Full Text] [Related]
5. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
Aghili M; Neelathahalli Kasturirangan M
JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
[TBL] [Abstract][Full Text] [Related]
6. Unit-based clinical pharmacists' prevention of serious medication errors in pediatric inpatients.
Kaushal R; Bates DW; Abramson EL; Soukup JR; Goldmann DA
Am J Health Syst Pharm; 2008 Jul; 65(13):1254-60. PubMed ID: 18574016
[TBL] [Abstract][Full Text] [Related]
7. Incidence of adverse drug events in an academic hospital: a prospective cohort study.
Aljadhey H; Mahmoud MA; Mayet A; Alshaikh M; Ahmed Y; Murray MD; Bates DW
Int J Qual Health Care; 2013 Dec; 25(6):648-55. PubMed ID: 24141014
[TBL] [Abstract][Full Text] [Related]
8. A new approach on assessing clinical pharmacists' impact on prescribing errors in a surgical intensive care unit.
Kessemeier N; Meyn D; Hoeckel M; Reitze J; Culmsee C; Tryba M
Int J Clin Pharm; 2019 Oct; 41(5):1184-1192. PubMed ID: 31332648
[TBL] [Abstract][Full Text] [Related]
9. The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit.
Chen CC; Hsiao FY; Shen LJ; Wu CC
Medicine (Baltimore); 2017 Aug; 96(34):e7883. PubMed ID: 28834903
[TBL] [Abstract][Full Text] [Related]
10. Characterising the complexity of medication safety using a human factors approach: an observational study in two intensive care units.
Carayon P; Wetterneck TB; Cartmill R; Blosky MA; Brown R; Kim R; Kukreja S; Johnson M; Paris B; Wood KE; Walker J
BMJ Qual Saf; 2014 Jan; 23(1):56-65. PubMed ID: 24050986
[TBL] [Abstract][Full Text] [Related]
11. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.
Bates DW; Cullen DJ; Laird N; Petersen LA; Small SD; Servi D; Laffel G; Sweitzer BJ; Shea BF; Hallisey R
JAMA; 1995 Jul; 274(1):29-34. PubMed ID: 7791255
[TBL] [Abstract][Full Text] [Related]
12. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units.
Cullen DJ; Sweitzer BJ; Bates DW; Burdick E; Edmondson A; Leape LL
Crit Care Med; 1997 Aug; 25(8):1289-97. PubMed ID: 9267940
[TBL] [Abstract][Full Text] [Related]
13. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
Kopp BJ; Mrsan M; Erstad BL; Duby JJ
Am J Health Syst Pharm; 2007 Dec; 64(23):2483-7. PubMed ID: 18029956
[TBL] [Abstract][Full Text] [Related]
14. Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment.
Jiang SP; Xu YY; Ping-Yang ; Wu WF; Zhang XG; Lu XY; Xiao YH; Liang WF; Chen J
Eur J Intern Med; 2014 Dec; 25(10):930-5. PubMed ID: 25153537
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory Computerized Prescribing and Preventable Adverse Drug Events.
Overhage JM; Gandhi TK; Hope C; Seger AC; Murray MD; Orav EJ; Bates DW
J Patient Saf; 2016 Jun; 12(2):69-74. PubMed ID: 26001546
[TBL] [Abstract][Full Text] [Related]
16. Role of pharmacist counseling in preventing adverse drug events after hospitalization.
Schnipper JL; Kirwin JL; Cotugno MC; Wahlstrom SA; Brown BA; Tarvin E; Kachalia A; Horng M; Roy CL; McKean SC; Bates DW
Arch Intern Med; 2006 Mar; 166(5):565-71. PubMed ID: 16534045
[TBL] [Abstract][Full Text] [Related]
17. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.
Kunac DL; Kennedy J; Austin N; Reith D
Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935
[TBL] [Abstract][Full Text] [Related]
18. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors.
Bates DW; Leape LL; Cullen DJ; Laird N; Petersen LA; Teich JM; Burdick E; Hickey M; Kleefield S; Shea B; Vander Vliet M; Seger DL
JAMA; 1998 Oct; 280(15):1311-6. PubMed ID: 9794308
[TBL] [Abstract][Full Text] [Related]
19. The effect of the TIM program (Transfer ICU Medication reconciliation) on medication transfer errors in two Dutch intensive care units: design of a prospective 8-month observational study with a before and after period.
Bosma BE; Meuwese E; Tan SS; van Bommel J; Melief PH; Hunfeld NG; van den Bemt PM
BMC Health Serv Res; 2017 Feb; 17(1):124. PubMed ID: 28183302
[TBL] [Abstract][Full Text] [Related]
20. Pharmacist- versus physician-initiated admission medication reconciliation: impact on adverse drug events.
Mergenhagen KA; Blum SS; Kugler A; Livote EE; Nebeker JR; Ott MC; Signor D; Sung S; Yeh J; Boockvar KS
Am J Geriatr Pharmacother; 2012 Aug; 10(4):242-50. PubMed ID: 22819386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
